Skip to main content

Table 4 Summary of clinicopathological parameters of the study cohort

From: Identification of novel long non-coding RNAs in clear cell renal cell carcinoma

 

Screening cohort

Validation cohort

 

n= 15 (%)

Cancer n= 55 (%)

Normal n= 52 (%)

Sex

   

  Male

10 (66.6)

37 (67.3)

36 (69.2)

  Female

5 (33.3)

18 (33.7)

16 (30.8)

Age

   

  Mean

61.2

62.9

62.1

  Min-max

43–86

36–86

36–86

Pathological stage

   

  pT1

4 (26.7)

29 (52.7)

n.a.

  pT2

2 (13.3)

7 (12.7)

n.a.

  pT3

9 (60.0)

18 (32.7)

n.a.

  pT4

0 (0)

1 (1.8)

n.a.

  Vascular invasion

7 (46.7)

16 (29.1)

n.a.

  Lymph node metastasis

0 (0)

2 (3.6)

n.a.

  Distant metastasis

1 (6.7)

7 (12.7)

n.a.

AJCC staging group

   

  I

4 (26.7)

26 (47.3)

n.a.

  II

1 (6.7)

5 (9.1)

n.a.

  III

9 (60.0)

16 (29.1)

n.a.

  IV

1 (6.7)

8 (14.5)

n.a.

Fuhrman grading

   

  Grade 1

2 (13.3)

4 (7.3)

n.a.

  Grade 2

11 (73.3)

41 (74.5)

n.a.

  Grade 3

2 (13.3)

9 16.3)

n.a.

  Grade 4

0 (0)

1 (1.8)

n.a.

  1. n.a. not applicable.